Stay updated on Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.

Latest updates to the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed from the record history. This updates the page’s version log to reflect the latest changes.SummaryDifference0.1%

- Check26 days agoChange DetectedNew history entry added for Revision v3.4.3 with a Study Status update, and the previous Revision v3.4.2 entry (dated 2025-11-20) was removed.SummaryDifference0.4%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 to the history; removed the Notice about lapse in government funding and Revision: v3.4.1.SummaryDifference0.6%

- Check61 days agoChange DetectedAdded a government funding notice and the latest revision entry (v3.4.1); removed the previous revision entry (v3.4.0) from the history.SummaryDifference0.6%

- Check69 days agoChange DetectedShow glossary feature added and a color-coded legend explaining additions and deletions. The revision note is updated to v3.4.0 and the older No FEAR Act data label and v3.3.4 reference were removed.SummaryDifference0.8%

- Check83 days agoChange DetectedRecord History shows a new revision entry: Revision v3.3.4 replacing v3.3.3, indicating a metadata update to the page history.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.